Skip to main content

Inhibikase Therapeutics, Inc 10-Q for FY2021 Q2

Inhibikase Therapeutics, Inc. (IKT)

10-Q 2021-08-16 For: 2021-06-30
View Original
Added on April 07, 2026

About this 10-Q

Inhibikase Therapeutics, Inc filed this 10-Q on August 16, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).

Headline figures

Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.36M
up 520.7% from $219.59K a year earlier
Net loss
$2.64M
compared with a net loss of $421.87K a year earlier